{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T23:47:00Z","timestamp":1649202420315},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.medcli.2012.05.028","type":"journal-article","created":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T05:03:02Z","timestamp":1343451782000},"page":"542-546","source":"Crossref","is-referenced-by-count":6,"title":["S\u00edndrome metab\u00f3lico en pacientes esquizofr\u00e9nicos con tratamiento antipsic\u00f3tico"],"prefix":"10.1016","volume":"139","author":[{"given":"Eva","family":"Aguilar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"Coronas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assumpta","family":"Caix\u00e0s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2012.05.028_bib0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.31887\/DCNS.2010.12.3\/mlambert","article-title":"Remission in schizophrenia: validity, frequency, predictors, and patients\u2019 perspective 5 years later","volume":"12","author":"Lambert","year":"2010","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.medcli.2012.05.028_bib0010","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome--a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2012.05.028_bib0015","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2012.05.028_bib0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/j.2051-5545.2009.tb00199.x","article-title":"Metabolic syndrome in people with schizophrenia: a review","volume":"8","author":"De Hert","year":"2009","journal-title":"World Psychiatry"},{"key":"10.1016\/j.medcli.2012.05.028_bib0025","doi-asserted-by":"crossref","unstructured":"Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu W, De Hert M. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis. Schizophr Bull. 2011. [Epub ahead of print]. PMID: 222007632.","DOI":"10.1093\/schbul\/sbr148"},{"key":"10.1016\/j.medcli.2012.05.028_bib0030","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1464-5491.2007.02092.x","article-title":"Impaired glucose tolerance in first-episode drug-na\u00efve patients with schizophrenia","volume":"24","author":"Spelman","year":"2007","journal-title":"Diabet Med"},{"key":"10.1016\/j.medcli.2012.05.028_bib0035","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1192\/bjp.bp.108.052605","article-title":"Metabolic profile of antipsychotic-naive individuals with non-affective psychosis","volume":"194","author":"Fernandez-Egea","year":"2009","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.medcli.2012.05.028_bib0040","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","article-title":"Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia","volume":"160","author":"Ryan","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.medcli.2012.05.028_bib0045","doi-asserted-by":"crossref","first-page":"997","DOI":"10.4088\/JCP.08m04508","article-title":"Metabolic risk factors in drug-naive patients with first-episode psychosis","volume":"70","author":"Verma","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.medcli.2012.05.028_bib0050","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":"11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)","volume":"374","author":"Tiihonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2012.05.028_bib0055","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2012.05.028_bib0060","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/YIC.0b013e32834a5bf6","article-title":"The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs","volume":"26","author":"Falissard","year":"2011","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.medcli.2012.05.028_bib0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1600-0447.2008.01334.x","article-title":"Which comes first: atypical antipsychotic treatment or cardiometabolic risk?","volume":"119","author":"Stahl","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.medcli.2012.05.028_bib0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3904\/kjim.2010.25.2.168","article-title":"The contribution of abdominal obesity and dyslipidemia to metabolic syndrome in psychiatric patients","volume":"25","author":"Kim","year":"2010","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.medcli.2012.05.028_bib0075","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4088\/JCP.08r04392","article-title":"Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review","volume":"70","author":"Simon","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.medcli.2012.05.028_bib0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.schres.2006.08.017","article-title":"Does antipsychotic polypharmacy increase the risk for metabolic syndrome?","volume":"89","author":"Correll","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.medcli.2012.05.028_bib0085","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-244X-11-118","article-title":"Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional study","volume":"11","author":"Misawa","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.medcli.2012.05.028_bib0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S0033291709990407","article-title":"Weight gain in antipsychotic-naive patients: a review and meta-analysis","volume":"40","author":"Tarricone","year":"2010","journal-title":"Psychol Med"},{"key":"10.1016\/j.medcli.2012.05.028_bib0095","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1157\/13093733","article-title":"Valoraci\u00f3n y control del riesgo metab\u00f3lico y cardiovascular en los pacientes con esquizofrenia","volume":"127","author":"Rodr\u00edguez-Artalejo","year":"2006","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2012.05.028_bib0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2010.07.012","article-title":"Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis","volume":"123","author":"Rummel-Kluge","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.medcli.2012.05.028_bib0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11892-010-0112-8","article-title":"Metabolic syndrome associated with schizophrenia and atypical antipsychotics","volume":"10","author":"Hasnain","year":"2010","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.medcli.2012.05.028_bib0110","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4088\/JCP.10m06822","article-title":"Prediabetes in patients treated with antipsychotic drugs","volume":"73","author":"Manu","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.medcli.2012.05.028_bib0115","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.medcli.2012.05.028_bib0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1192\/bjp.bp.110.084665","article-title":"Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation","volume":"199","author":"De Hert","year":"2011","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.medcli.2012.05.028_bib0125","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1467-789X.2009.00570.x","article-title":"Efficacy of behavioural interventions in managing atypical antipsychotic weight gain","volume":"10","author":"Gabriele","year":"2009","journal-title":"Obes Rev"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775312005660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775312005660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T09:03:10Z","timestamp":1642928590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775312005660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0025775312005660"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2012.05.028","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}